Fmoc-L-allo-isoleucine

Fmoc-L-allo-isoleucine is an Fmoc-protected L-allo-isoleucine amino acid derivative in which the amino group is masked by the 9H-fluorenylmethoxycarbonyl (Fmoc) group, enabling orthogonal protection during peptide assembly. The molecule retains the chiral, branched aliphatic side chain characteristic of isoleucine while differing at the allo stereochemical relationship, which can influence conformational preferences and steric presentation in peptide backbones and peptidomimetics. The free carboxyl functionality is typically present as the carboxylic acid form for coupling chemistry, while the Fmoc carbamate provides stability under base-labile conditions and can be removed to regenerate the nucleophilic amine for iterative synthesis. The combination of a stereodefined amino acid core and an acid-labile/amine-reactive coupling handle makes Fmoc-L-allo-isoleucine a practical chiral building block for protected amino acid synthesis and downstream derivative formation.

1. Peptide Synthesis

Fmoc-L-allo-isoleucine is used in automated and manual solid-phase peptide synthesis workflows where Fmoc protection supports stepwise N-terminal elongation. The protected amine and carboxylic acid functionality enable standard peptide coupling strategies, while the allo-configured stereocenter in the branched side chain provides a distinct steric and conformational signature compared with conventional isoleucine residues. Fmoc deprotection regenerates the reactive amine for subsequent coupling cycles, allowing incorporation into peptides, peptide fragments, and sequence-defined analogs. The resulting peptide products can be used to probe backbone/side-chain recognition, generate sequence libraries, and support synthetic methodology development in amino acid chemistry.

2. Peptidomimetics And SAR Studies

Fmoc-L-allo-isoleucine is applied in medicinal chemistry research for constructing peptidomimetics and constrained analogs where side-chain stereochemistry affects molecular shape and binding-site complementarity. The branched aliphatic side chain, presented with allo stereochemistry, can be incorporated into SAR studies to evaluate how subtle stereochemical changes alter hydrophobic contacts and local conformational bias. Fmoc-protected incorporation into peptide-like scaffolds facilitates parallel synthesis of analog panels, followed by functional group transformations that may include side-chain derivatization or backbone modification. The amino acid building block nature of Fmoc-L-allo-isoleucine also supports fragment assembly strategies that feed into structure-guided optimization and analytical characterization.

3. Protein Engineering

Fmoc-L-allo-isoleucine is suitable for protein engineering and chemical protein modification efforts that require stereochemically defined residues within peptide segments or protein-derived constructs. The Fmoc-protected amino acid form enables controlled incorporation into synthetic peptides used as substrates, standards, or binding probes that mimic protein regions containing branched hydrophobic side chains. Allo stereochemistry can be leveraged to create peptides with altered steric profiles, supporting studies of folding propensity, protease recognition, and interaction specificity in engineered systems. Downstream, the synthesized peptide motifs can be conjugated to carriers or used as reference materials in protein-interaction assays and protein engineering workflows.

4. Chemical Biology Probes

Fmoc-L-allo-isoleucine is employed in chemical biology research to generate labeled peptide probes and recognition elements where N-protected amino acid chemistry supports reliable assembly. The Fmoc group enables clean iterative coupling to produce peptides bearing defined sequences that can later be functionalized for conjugation, such as introducing reactive handles for biophysical labeling or immobilization. Allo isoleucine stereochemistry can influence peptide uptake, receptor binding, or enzyme processing in probe designs by modulating side-chain orientation and hydrophobic packing. The resulting peptide probes serve as biochemical research intermediates for target engagement studies, pathway mapping, and assay development.

5. Pharmaceutical Manufacturing Intermediates

Fmoc-L-allo-isoleucine is applicable to pharmaceutical manufacturing and fine chemical synthesis contexts where protected amino acid building blocks are required for controlled peptide intermediate preparation. The Fmoc-protected amine supports robust handling and compatibility with peptide coupling chemistries used to generate drug-like peptide fragments and processable intermediates. Allo stereochemistry provides a defined chiral input that can be carried through manufacturing routes to maintain stereochemical integrity in final peptide products or advanced intermediates. The compound's protected amino acid structure also fits into industrial process chemistry needs for reproducible peptide synthesis steps, purification planning, and scalable intermediate generation for downstream formulation work.

6. Analytical Standards for Stereochemical Studies

Fmoc-L-allo-isoleucine is used to prepare analytical standards and reference materials for stereochemical verification in amino acid and peptide characterization workflows. The defined allo stereochemistry and Fmoc-protected identity allow the compound to be incorporated into peptides that can serve as LC-MS, HPLC, or MS/MS reference species for distinguishing stereoisomeric residues. Fmoc-based peptide construction supports generation of sequence-specific standards that reflect how stereochemistry impacts retention behavior and fragmentation patterns. The resulting reference materials can be employed in method development, impurity profiling, and quality-focused analytical research tied to amino acid derivatization and protected amino acid synthesis.

1. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy

2. Proinsulin C-peptide and insulin: Limited pattern similarities of interest in inter-peptide interactions but no C-peptide effect on insulin and IGF-1 receptor signaling

3. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis

4. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die

5. Myotropic activity of allatostatins in tenebrionid beetles